683219-25-2 Usage
Uses
Used in Pharmaceutical Research:
3-[(tert-butoxycarbonyl)amino]-3-[3-(trifluoromethyl)phenyl]propanoic acid is used as a building block in the synthesis of various pharmaceuticals and bioactive compounds. Its specific properties and applications make it an important chemical in the field of medicinal chemistry and drug discovery.
Used in Drug Design and Development:
In the pharmaceutical industry, 3-[(tert-butoxycarbonyl)amino]-3-[3-(trifluoromethyl)phenyl]propanoic acid is used as a key intermediate for the development of new drugs. Its Boc-protected amino group and trifluoromethylphenyl group provide unique structural features that can be exploited to enhance the potency, selectivity, and pharmacokinetic properties of drug candidates.
Used in Medicinal Chemistry:
3-[(tert-butoxycarbonyl)amino]-3-[3-(trifluoromethyl)phenyl]propanoic acid is utilized in medicinal chemistry for the design and optimization of bioactive molecules. Its unique structural elements can be incorporated into various chemical scaffolds to modulate biological activity and improve drug-like properties, such as solubility, stability, and bioavailability.
Check Digit Verification of cas no
The CAS Registry Mumber 683219-25-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,8,3,2,1 and 9 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 683219-25:
(8*6)+(7*8)+(6*3)+(5*2)+(4*1)+(3*9)+(2*2)+(1*5)=172
172 % 10 = 2
So 683219-25-2 is a valid CAS Registry Number.
683219-25-2Relevant academic research and scientific papers
SUBSTITUTED BENZIMIDAZOLES AS POTASSIUM CHANNEL INHIBITORS
-
Page/Page column 65; 66, (2019/03/05)
The present invention relates to a compound of the general formula (I). The compounds of formula I are useful for treatment of a cardiac disease, disorder or condition in a mammal.
BENZIMIDAZOLE DERIVATIVES USEFUL AS POTASSIUM CHANNEL INHIBITORS
-
Page/Page column 61; 62, (2019/03/12)
The present invention relates to compounds of the general formula (I). The compounds of formula I are potassium channel inhibitors useful for treatment of a cardiac disease, disorder or condition in a mammal.
NOVEL POTASSIUM CHANNEL INHIBITORS
-
Page/Page column 106, (2017/09/15)
The present invention relates to a compound of the general formula (I). The compounds of formula (I) are useful for treatment of a cardiac disease, disorder or condition in a mammal.
